Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus

Search Close Search
Search Close Search
Page Menu

Leading Innovation at Intellia

Lunch and Learn

Leading Innovation at Intellia

 

Laura Sepp-Laurenzino

Chief Scientific Officer, Intellia therapeutics 

Wednesday February 19th

12:00-12:45 pm Seminar

12:45-1:15 pm career chat

Albert Sherman AS4-2072

Lunch will be provided

 

 

Please RSVP here if you are attending 

 

Laura is currently the chief scientific officer at Intellia Therapeutics, biotech company that develops biopharmaceuticals using CRISPR gene-editing technology. Laura is an innovative leader in drug discovery and development of small molecule and oligonucleotide therapeutics, with over 20 years of experience in academic and industrial settings. 
She defines and implements internal and external research strategy, incorporating disruptive, enabling technologies. Dr. Sepp-Lorenzino builds responsive, collaborative teams across geographies and functions and nurtures a learning environment across the organization; coaching, mentoring. She optimizes operations and cost structures, delivering on objectives.

 

October 1, 2020 - October 31, 2020

SEPT
NOV
2020